Evidence map›Paper›PMID 32800929›Full record

SynthesisJournal of ethnopharmacology2021

A comprehensive review on traditional uses, chemical compositions, pharmacology properties and toxicology of Tetrastigma hemsleyanum.

Tao Ji, Wei Wei Ji, Juan Wang, Hong Jiang Chen, Xin Peng, Ke Jun Cheng, Dan Qiu, Wei Jie Yang

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Journal of ethnopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Screening out Biomarkers ofMolecules (Basel, Switzerland) · 2023
    Article
  15. Phylogenetic Analysis ofBiomolecules · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Flavonoid Metabolism inMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Tao JiZhejiang Pharmaceutical College, Ningbo, 315100, Zhejiang, People's Republic of China.
Wei Wei JiZhejiang Pharmaceutical College, Ningbo, 315100, Zhejiang, People's Republic of China.
Juan WangZhejiang Pharmaceutical College, Ningbo, 315100, Zhejiang, People's Republic of China.
Hong Jiang ChenZhejiang Pharmaceutical College, Ningbo, 315100, Zhejiang, People's Republic of China.
Xin PengNingbo Research Institute of Zhejiang University, Ningbo, 315100, Zhejiang, People's Republic of China. Electronic address: px4142@163.com.
Ke Jun ChengChemical Biology Center, Lishui Institute of Agriculture and Forestry Sciences, Lishui, 323000, Zhejiang, People's Republic of China.
Dan QiuFeng Hua Institute of Science and Technology, Ningbo University of Technology, Ningbo, 315100, Zhejiang, People's Republic of China.
Wei Jie YangFeng Hua Institute of Science and Technology, Ningbo University of Technology, Ningbo, 315100, Zhejiang, People's Republic of China.
Zhejiang Pharmaceutical College · CNNingbo University of Technology · CNLishui Academy of Forestry · CNNingbo University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ethnopharmacological relevanceTetrastigma hemsleyanum Diels et Gilg (T.hemsleyanum), a rare herbal plant distributed in subtropical areas of mainland China, has become a focus of scientific attention in recent years because of its high traditional value, including uses for treatment of children with fever, pneumonia, asthma, rheumatism, hepatitis, menstrual disorders, scrofula, and pharynx pain.

aimThis systematic review aims to provide an insightful understanding of traditional uses, chemical composition, pharmacological effect and clinical application of T. hemsleyanum, and lay a foundation for the further study and for the utilization of T. hemsleyanum resource. MATERIALS AND

methodsA domestic and overseas literature search in known databases was conducted for published articles using the relevant keywords.

resultsOne hundred and forty-two chemical constituents identified from T. hemsleyanum have been reported, including flavonoids, phenolic acids, polysaccharide, organic acids, fatty acids, terpenoids, steroids, amino acid and others. Among these components, flavonoids and polysaccharides were the representative active ingredients of T. hemsleyanum, which have been widely investigated. Modern pharmacological studies have shown that these components exhibited various pharmacological activities, such as anti-inflammatory, antioxidant, antivirus, antitumor, antipyretic, anti-hepatic injury, immunomodulatory, antibacterial etc. Moreover, different toxicological studies indicated that the clinical dosage of T. hemsleyanum was safe and reliable.

conclusionsModern pharmacological studies have well supported and clarified some traditional uses, and T. hemsleyanum has a good prospect for the development of new drugs due to these outstanding properties. However, the present findings did not provide an in-depth evaluation of bioactivity of the extracts, the composition of its active extracts was not clear. Moreover, they were insufficient to satisfactorily explain some mechanisms of action. Data regarding many aspects of T. hemsleyanum, such as links between the traditional uses and bioactivities, pharmacokinetics, quality control standard and the clinical value of active compositions is still limited which need more attention.

Indexed as

Plants, MedicinalAnimalsAntineoplastic Agents, PhytogenicDrugs, Chinese HerbalEthnopharmacologyHumansMedicine, Chinese TraditionalPhytochemicalsAntineoplastic Agents, PhytogenicDrugs, Chinese HerbalPhytochemicalsChemical compositionPharmacological activityTetrastigma hemsleyanumToxicologyTraditional uses

Identifiers

PMID32800929
PMCPMC7422820
OpenAlexW3048681886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.